David Bizousky, MD
Sports Medicine · Indiana, PANPI 1235199910
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,650 of the $10,984 with a category attached, or 60.5%. Regeneron accounts for 60.5% of it on its own, with 14 other manufacturers making up the rest.
Across 79 payments — averaging $139.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$7K
- Smith+Nephew$3K
- Bioventus LLC$396
- Stryker$247
- Innovation Technologies Inc$134
- Ferring Pharmaceuticals Inc.$127
- plus $286 from 9 others
Across 58 payments — averaging $7008.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$224K
- Novartis$135K
- Endo Pharmaceuticals Inc.$43K
- IBSA Institut Biochimique SA$4K
- GRT US Holding, Inc.$700
What the payments were for
- Consulting fees$6,65061%
- Travel & lodging$2,16220%
- Food & beverage$2,17220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $6,650 |
| Smith+Nephew | 27 | $3,143 |
| Bioventus LLC | 15 | $396 |
| Stryker | 8 | $247 |
| Innovation Technologies Inc | 3 | $134 |
| Ferring Pharmaceuticals Inc. | 7 | $127 |
| Pfizer | 5 | $77 |
| Cumberland Pharmaceuticals, Inc. | 4 | $62 |
| Novo Nordisk | 2 | $35 |
| Johnson & Johnson | 1 | $33 |
| Abbott | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Zimmer Biomet | 1 | $17 |
| Baudax Bio Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,086
- RI.HIP NAVIGATION$2,086
- JOURNEY$2,086
- REAL INTELLIGENCE$1,130
- Legion Revision$956
- OR3O Dual Mobility$956
- POLARSTEM$397
How this compares
$10,984 in reported general payments places this provider in the 85th percentile of 311 sports medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CeftriaxoneCeftriaxone Sodium | 33 | $2,247 |
| Meloxicam | 101 | $379 |
| Methylprednisolone | 35 | $259 |
| Amoxicillin | 102 | $118 |
| Prednisone | 40 | $111 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $78 |
| Cephalexin | 28 | $74 |
| Tramadol Hcl | 51 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $54 |
| Baclofen | 11 | $22 |
| Clindamycin Hcl | 17 | $20 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Indiana
- Brian StoneIndiana$7K
- Sam AkhavanPittsburgh$2.2M
- Albert LinPittsburgh$460K
- Sommer HammoudPhiladelphia$238K
- Theresa PazionisPhiladelphia$235K
- Matthew Varacallodu Bois$129K
- Matthew BestAllentown$77K
- Marco AlcalaCanonsburg$54K
- Brandon TaubergWashington$54K
- Alexander JohnsonBethlehem$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.